[Prevalence of metabolic complications after 10 years of antiretroviral treatment in Senegal].

Abstract

Among the patients of the cohort still followed after a median of 9 years of antiretroviral treatment (ART), 37% had lipodystrophy, 28% had hypertension and 14% presented with diabetes. This study confirms the association between stavudine and lipodystrophy particulary lipoatrophy and shows that a longer duration of ART was associated with the presence of diabetes. These results highlight the need to implement programs for prevention of cardiovascular risk factors in HIV patients from resource-constrained settings.

• Authors: A Diouf, A Cournil, groupe d’étude de la Cohorte ANRS 1215
• Journal: Bulletin de la Societe de pathologie exotique (1990) (Bull Soc Pathol Exot) Vol. 107 Issue 4 Pg. 234-7 (Oct 2014) ISSN: 1961-9049 [Electronic] France
• Vernacular Title: Prévalence des complications métaboliques à 10 ans de traitements antirétroviraux au Sénégal.
• PMID: 24683016 (Publication Type: English Abstract, Journal Article)

Chemical References

• Anti-HIV Agents
• Stavudine

Topics

• Anti-HIV Agents (therapeutic use)
• Antiretroviral Therapy, Highly Active (adverse effects)
• Cardiovascular Diseases (chemically induced, epidemiology)
• Diabetes Mellitus (chemically induced, epidemiology)
• Female
• Follow-Up Studies
• HIV Infections (complications, epidemiology)
• HIV-Associated Lipodystrophy Syndrome (chemically induced)
• Humans
• Lipodystrophy (chemically induced)
• Male
• Metabolic Diseases (chemically induced, epidemiology)
• Middle Aged
• Senegal (epidemiology)
• Stavudine (therapeutic use)